Importance Within 2 decades of onset, 80% of untreated patients with relapsing-remitting
multiple sclerosis (MS) convert to a phase of irreversible disability accrual termed secondary …

Difficulty in walking is a major feature of neurological disease, and loss of mobility is the
activity of daily living on which patients place the most value. 1 Consequently, how to measure …

Background Progressive disability in multiple sclerosis occurs because CNS axons
degenerate as a late consequence of demyelination. In animals, retinoic acid receptor RXR-gamma …

Background: A direct quantitative measurement of locomotor activity in an individual’s own
environment over an extended period may help in evaluating the impact of impairments in …

Background: People with MS (pwMS) have had higher rates of anxiety and depression than
the general population before the COVID-19 pandemic, placing them at higher risk of …

Neurologists increasingly use anti-CD20 therapies, including for women of childbearing age,
despite these medications being unlicensed for use in pregnancy. Current evidence …

Background Infections can trigger exacerbations of multiple sclerosis (MS). The effects of the
coronavirus disease 2019 (COVID-19) on MS are not known. The aim of this study was to …

We present a crystallography chip enabling in situ room temperature crystallography at
microfocus synchrotron beamlines and X-ray free-electron laser (X-FEL) sources. Compared to …

The negative impact of smoking in multiple sclerosis is well established; however, there is
much less evidence as to whether smoking cessation is beneficial to progression in multiple …

Patients with multiple sclerosis have long turned to complementary therapies to manage
symptoms that licensed products can only partially control. Around half of patients with multiple …